New trial aims to save rectums in early cancer patients
NCT ID NCT07563907
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding a short course of chemotherapy after standard chemoradiation can improve outcomes for people with stage I rectal cancer, allowing them to keep their rectum instead of needing major surgery. About 292 participants will be randomly assigned to receive either chemoradiation alone or chemoradiation plus extra chemotherapy before a minor surgical procedure. The goal is to see if the extra chemo leads to a complete disappearance of the tumor and reduces the chance of cancer coming back.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAPECITABINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Hospital
Seoul, Jongro-gu, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two-Drug combo aims to wipe out rectal cancer before surgery
- New drug combo aims to improve leukemia treatment before transplant
- Rectal cancer breakthrough: could a new drug combo save your rectum?
- Could storing lungs at 10°C improve transplant outcomes?
- New drug combo aims to keep High-Risk leukemia in remission before transplant
- New radiation boost strategy aims to spare rectal cancer patients from surgery